Global Stem Cell Therapy Market to Reach $977.1 Million by 2030
The global market for Stem Cell Therapy estimated at US$276.5 Million in the year 2022, is projected to reach a revised size of US$977.1 Million by 2030, growing at a CAGR of 17.1% over the analysis period 2022-2030. Allogeneic, one of the segments analyzed in the report, is projected to record 17.6% CAGR and reach US$936 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Autologous segment is readjusted to a revised 8.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $80.9 Million, While China is Forecast to Grow at 16.2% CAGR
The Stem Cell Therapy market in the U.S. is estimated at US$80.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$165.6 Million by the year 2030 trailing a CAGR of 16.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.5% and 14% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.Select Competitors (Total 12 Featured) -
- Advanced Cell Technology
- Anterogen, Ltd.
- Biotime, Osiris Therapeutics
- Cynata
- Cytori Therapeutics
- HolostemTerapieAvanzateS.r.l.
- Human Longevity
- JCR Pharmaceuticals
- Medipost
- Mesoblastand AlloSource
- NuVasive
- Osiris Therapeutics, Inc.
- Pharmicell
- Promethera Biosciences
- RTI Surgical
- Stemcell Technologies
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Cell Technology
- Anterogen, Ltd.
- Biotime, Osiris Therapeutics
- Cynata
- Cytori Therapeutics
- HolostemTerapieAvanzateS.r.l.
- Human Longevity
- JCR Pharmaceuticals
- Medipost
- Mesoblastand AlloSource
- NuVasive
- Osiris Therapeutics, Inc.
- Pharmicell
- Promethera Biosciences
- RTI Surgical
- Stemcell Technologies
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 78 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 276.5 Million |
Forecasted Market Value ( USD | $ 977.1 Million |
Compound Annual Growth Rate | 17.1% |
Regions Covered | Global |